Bright Pharmaceuticals Pte. Ltd is a Singapore incorporated company with its main objective to produce and distribute active pharmaceutical raw materials and intermediates. We offer wide range of pharmaceutical products, customize synthesis services and contract manufacturing specific to customers?? specification.
We specialize in producing anti-epilepsy and anti-depressants API as well as Intermediates. Our range of manufacturing products includes Carbamzepine, Oxcarbamazepine, Bupropion Hydrochloride, Sodium Ozagrel, Setraline Hydrochloride and related intermediates.
Bright Chemicals (HK) Ltd, our Hong Kong subsidiary is a pharmaceutical products trading firm. With the good QA and QC assurance and support rendered from our China subsidiary, Bright Chemicals (HK) Ltd continue to penetrate pharmaceutical products exporting business and has since grown to be one of the leading pharmaceutical products exporters in the Asia region.
Bright Pharmaceuticals (Suzhou) Co., Ltd, our China subsidiary is a cGMP compliant manufacturing plant, comprising of a manufacturing plant, R&D department and QC laboratory. It is strategically situated in the Petrochemical Development Zone of Taichang, Jiangsu province which is about 40km from Shanghai.
Our range of API products are complied with US, British and European Pharmacopoeia last edition. We are now in the process of achieving for the widely recognized TGA GMP certification and FDA approval. Bright Pharmaceuticals (Suzhou) Co., Ltd aspire to become the key producer of Anti-Depressants and Anti-Epilepsy Active Pharmaceuticals Ingredients and its intermediates.
Bright Pharmaceuticals Pte Ltd is dedicated to building long-lasting relationships with customers through excellent quality products and customized services, and strikes to be recognized as one of the leading companies in the pharmaceutical industry.
China (Mainland)
